APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Menopause Supplement

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Menopause Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174012060323 December 2025195 pages

Choose your research edition.

Industry ResearchMenopause Supplement Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Menopause Supplement Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Menopause Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Menopause Supplement Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Menopause Supplement Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Menopause Supplement market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Menopause Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Menopause Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Menopause Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Menopause Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Menopause Supplement include Vitabiotics, The Better Menopause, SMPNutra, Promensil, PhytoLife Pharma, PharmaLinea, Otsuka Pharmaceutical, Nordic Naturals and New Nordic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Menopause Supplement market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Menopause Supplement and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Menopause Supplement sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Menopause Supplement market size, projected growth trends, production technologies, key applications, and end-use industries.

Menopause Supplement Segment by Company

Vitabiotics

The Better Menopause

SMPNutra

Promensil

PhytoLife Pharma

PharmaLinea

Otsuka Pharmaceutical

Nordic Naturals

New Nordic

Menopace

MenoLabs

Menoelle

Makers Nutrition

Kobayashi Pharmaceutical

GNC

Flourish

Equelle

Bonafide Health

Biofarma Group

Amerifit Brands(Estroven)

AdvaCare Pharma

Menopause Supplement Segment by Type

Bone Health Supplements

Hormone Regulation Supplements

Mood and Sleep Regulation Supplements

Cardiovascular and Metabolic Support Supplements

Others

Menopause Supplement Segment by Application

Online Pharmacies

Retail Pharmacies

Hospital

Menopause Supplement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Menopause Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Menopause Supplement market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Menopause Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Menopause Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Menopause Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Menopause Supplement Industry Trends Table 2. Menopause Supplement Industry Drivers Table 3. Menopause Supplement Industry Opportunities and Challenges Table 4. Menopause Supplement Industry Restraints Table 5. Global Menopause Supplement Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Menopause Supplement Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Menopause Supplement Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Menopause Supplement Sales Market Share by Manufacturers Table 9. Global Menopause Supplement Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Menopause Supplement Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Menopause Supplement Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Menopause Supplement Manufacturers, Product Type & Application Table 13. Global Menopause Supplement Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Menopause Supplement by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Bone Health Supplements Table 17. Major Manufacturers of Hormone Regulation Supplements Table 18. Major Manufacturers of Mood and Sleep Regulation Supplements Table 19. Major Manufacturers of Cardiovascular and Metabolic Support Supplements Table 20. Major Manufacturers of Others Table 21. Global Menopause Supplement Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Menopause Supplement Sales by Type (2021-2026) & (k units) Table 23. Global Menopause Supplement Sales by Type (2027-2032) & (k units) Table 24. Global Menopause Supplement Sales Market Share by Type (2021-2026) Table 25. Global Menopause Supplement Sales Market Share by Type (2027-2032) Table 26. Global Menopause Supplement Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Menopause Supplement Revenue by Type (2021-2026) & (k units) Table 28. Global Menopause Supplement Revenue by Type (2027-2032) & (k units) Table 29. Global Menopause Supplement Revenue Market Share by Type (2021-2026) Table 30. Global Menopause Supplement Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Online Pharmacies Table 32. Major Manufacturers of Retail Pharmacies Table 33. Major Manufacturers of Hospital Table 34. Global Menopause Supplement Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Menopause Supplement Sales by Application (2021-2026) & (k units) Table 36. Global Menopause Supplement Sales by Application (2027-2032) & (k units) Table 37. Global Menopause Supplement Sales Market Share by Application (2021-2026) Table 38. Global Menopause Supplement Sales Market Share by Application (2027-2032) Table 39. Global Menopause Supplement Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Menopause Supplement Revenue by Application (2021-2026) & (k units) Table 41. Global Menopause Supplement Revenue by Application (2027-2032) & (k units) Table 42. Global Menopause Supplement Revenue Market Share by Application (2021-2026) Table 43. Global Menopause Supplement Revenue Market Share by Application (2027-2032) Table 44. Global Menopause Supplement Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Menopause Supplement Sales by Region (2021-2026) & (k units) Table 46. Global Menopause Supplement Sales Market Share by Region (2021-2026) Table 47. Global Menopause Supplement Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Menopause Supplement Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Menopause Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Menopause Supplement Sales by Country (2021-2026) & (k units) Table 51. North America Menopause Supplement Sales by Country (2027-2032) & (k units) Table 52. Europe Menopause Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Menopause Supplement Sales by Country (2021-2026) & (k units) Table 54. Europe Menopause Supplement Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Menopause Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Menopause Supplement Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Menopause Supplement Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Menopause Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Menopause Supplement Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Menopause Supplement Sales by Country (2027-2032) & (k units) Table 61. Global Menopause Supplement Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Menopause Supplement Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Menopause Supplement Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Menopause Supplement Revenue Market Share by Region (2021-2026) Table 65. Global Menopause Supplement Revenue Market Share by Region (2027-2032) Table 66. Vitabiotics Company Information Table 67. Vitabiotics Business Overview Table 68. Vitabiotics Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Vitabiotics Menopause Supplement Product Portfolio Table 70. Vitabiotics Recent Development Table 71. The Better Menopause Company Information Table 72. The Better Menopause Business Overview Table 73. The Better Menopause Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. The Better Menopause Menopause Supplement Product Portfolio Table 75. The Better Menopause Recent Development Table 76. SMPNutra Company Information Table 77. SMPNutra Business Overview Table 78. SMPNutra Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. SMPNutra Menopause Supplement Product Portfolio Table 80. SMPNutra Recent Development Table 81. Promensil Company Information Table 82. Promensil Business Overview Table 83. Promensil Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Promensil Menopause Supplement Product Portfolio Table 85. Promensil Recent Development Table 86. PhytoLife Pharma Company Information Table 87. PhytoLife Pharma Business Overview Table 88. PhytoLife Pharma Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. PhytoLife Pharma Menopause Supplement Product Portfolio Table 90. PhytoLife Pharma Recent Development Table 91. PharmaLinea Company Information Table 92. PharmaLinea Business Overview Table 93. PharmaLinea Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. PharmaLinea Menopause Supplement Product Portfolio Table 95. PharmaLinea Recent Development Table 96. Otsuka Pharmaceutical Company Information Table 97. Otsuka Pharmaceutical Business Overview Table 98. Otsuka Pharmaceutical Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Otsuka Pharmaceutical Menopause Supplement Product Portfolio Table 100. Otsuka Pharmaceutical Recent Development Table 101. Nordic Naturals Company Information Table 102. Nordic Naturals Business Overview Table 103. Nordic Naturals Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Nordic Naturals Menopause Supplement Product Portfolio Table 105. Nordic Naturals Recent Development Table 106. New Nordic Company Information Table 107. New Nordic Business Overview Table 108. New Nordic Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. New Nordic Menopause Supplement Product Portfolio Table 110. New Nordic Recent Development Table 111. Menopace Company Information Table 112. Menopace Business Overview Table 113. Menopace Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Menopace Menopause Supplement Product Portfolio Table 115. Menopace Recent Development Table 116. MenoLabs Company Information Table 117. MenoLabs Business Overview Table 118. MenoLabs Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. MenoLabs Menopause Supplement Product Portfolio Table 120. MenoLabs Recent Development Table 121. Menoelle Company Information Table 122. Menoelle Business Overview Table 123. Menoelle Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Menoelle Menopause Supplement Product Portfolio Table 125. Menoelle Recent Development Table 126. Makers Nutrition Company Information Table 127. Makers Nutrition Business Overview Table 128. Makers Nutrition Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Makers Nutrition Menopause Supplement Product Portfolio Table 130. Makers Nutrition Recent Development Table 131. Kobayashi Pharmaceutical Company Information Table 132. Kobayashi Pharmaceutical Business Overview Table 133. Kobayashi Pharmaceutical Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Kobayashi Pharmaceutical Menopause Supplement Product Portfolio Table 135. Kobayashi Pharmaceutical Recent Development Table 136. GNC Company Information Table 137. GNC Business Overview Table 138. GNC Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. GNC Menopause Supplement Product Portfolio Table 140. GNC Recent Development Table 141. Flourish Company Information Table 142. Flourish Business Overview Table 143. Flourish Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Flourish Menopause Supplement Product Portfolio Table 145. Flourish Recent Development Table 146. Equelle Company Information Table 147. Equelle Business Overview Table 148. Equelle Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Equelle Menopause Supplement Product Portfolio Table 150. Equelle Recent Development Table 151. Bonafide Health Company Information Table 152. Bonafide Health Business Overview Table 153. Bonafide Health Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Bonafide Health Menopause Supplement Product Portfolio Table 155. Bonafide Health Recent Development Table 156. Biofarma Group Company Information Table 157. Biofarma Group Business Overview Table 158. Biofarma Group Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Biofarma Group Menopause Supplement Product Portfolio Table 160. Biofarma Group Recent Development Table 161. Amerifit Brands(Estroven) Company Information Table 162. Amerifit Brands(Estroven) Business Overview Table 163. Amerifit Brands(Estroven) Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Amerifit Brands(Estroven) Menopause Supplement Product Portfolio Table 165. Amerifit Brands(Estroven) Recent Development Table 166. AdvaCare Pharma Company Information Table 167. AdvaCare Pharma Business Overview Table 168. AdvaCare Pharma Menopause Supplement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. AdvaCare Pharma Menopause Supplement Product Portfolio Table 170. AdvaCare Pharma Recent Development Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Menopause Supplement Distributors List Table 174. Menopause Supplement Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Menopause Supplement Product Image Figure 2. Global Menopause Supplement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Menopause Supplement Market Size (2021-2032) & (US$ Million) Figure 4. Global Menopause Supplement Sales (2021-2032) & (k units) Figure 5. Global Menopause Supplement Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Menopause Supplement Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Bone Health Supplements Image Figure 9. Hormone Regulation Supplements Image Figure 10. Mood and Sleep Regulation Supplements Image Figure 11. Cardiovascular and Metabolic Support Supplements Image Figure 12. Others Image Figure 13. Global Menopause Supplement Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Menopause Supplement Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Menopause Supplement Sales Market Share by Type (2021-2032) Figure 16. Global Menopause Supplement Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Menopause Supplement Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Menopause Supplement Revenue Market Share by Type (2021-2032) Figure 19. Online Pharmacies Image Figure 20. Retail Pharmacies Image Figure 21. Hospital Image Figure 22. Global Menopause Supplement Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Menopause Supplement Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Menopause Supplement Sales Market Share by Application (2021-2032) Figure 25. Global Menopause Supplement Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Menopause Supplement Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Menopause Supplement Revenue Market Share by Application (2021-2032) Figure 28. North America Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Menopause Supplement Sales Market Share by Country (2021-2032) Figure 30. U.S. Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Menopause Supplement Sales Market Share by Country (2021-2032) Figure 35. Germany Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Menopause Supplement Sales Market Share by Country (2021-2032) Figure 42. China Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Menopause Supplement Sales Market Share by Country (2021-2032) Figure 50. Brazil Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Menopause Supplement Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Menopause Supplement Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Menopause Supplement Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Menopause Supplement Revenue (2021-2032) & (US$ Million) Figure 61. North America Menopause Supplement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Menopause Supplement Revenue (2021-2032) & (US$ Million) Figure 63. Europe Menopause Supplement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Menopause Supplement Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Menopause Supplement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Menopause Supplement Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Menopause Supplement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Menopause Supplement Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Menopause Supplement Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Bone Health Supplements
  • Hormone Regulation Supplements
  • Mood and Sleep Regulation Supplements
  • Cardiovascular and Metabolic Support Supplements
  • Others
Applications
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital
Companies covered
  • Vitabiotics
  • The Better Menopause
  • SMPNutra
  • Promensil
  • PhytoLife Pharma
  • PharmaLinea
  • Otsuka Pharmaceutical
  • Nordic Naturals
  • New Nordic
  • Menopace
  • MenoLabs
  • Menoelle
  • Makers Nutrition
  • Kobayashi Pharmaceutical
  • GNC
  • Flourish
  • Equelle
  • Bonafide Health
  • Biofarma Group
  • Amerifit Brands(Estroven)
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Menopause Supplement Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Menopause Supplement Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Menopause Supplement Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Menopause Supplement Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Menopause Supplement Market Dynamics
  1. 2.1 Menopause Supplement Industry Trends
  2. 2.2 Menopause Supplement Industry Drivers
  3. 2.3 Menopause Supplement Industry Opportunities and Challenges
  4. 2.4 Menopause Supplement Industry Restraints
3 Menopause Supplement Market by Manufacturers
  1. 3.1 Global Menopause Supplement Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Menopause Supplement Sales by Manufacturers (2021-2026)
  3. 3.3 Global Menopause Supplement Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Menopause Supplement Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Menopause Supplement Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Menopause Supplement Manufacturers, Product Type & Application
  7. 3.7 Global Menopause Supplement Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Menopause Supplement Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Menopause Supplement Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Menopause Supplement Tier 1, Tier 2, and Tier 3
4 Menopause Supplement Market by Type
  1. 4.1 Menopause Supplement Type Introduction
  2. 4.1.1 Bone Health Supplements
  3. 4.1.2 Hormone Regulation Supplements
  4. 4.1.3 Mood and Sleep Regulation Supplements
  5. 4.1.4 Cardiovascular and Metabolic Support Supplements
  6. 4.1.5 Others
  7. 4.2 Global Menopause Supplement Sales by Type
  8. 4.2.1 Global Menopause Supplement Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Menopause Supplement Sales by Type (2021-2032)
  10. 4.2.3 Global Menopause Supplement Sales Market Share by Type (2021-2032)
  11. 4.3 Global Menopause Supplement Revenue by Type
  12. 4.3.1 Global Menopause Supplement Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Menopause Supplement Revenue by Type (2021-2032)
  14. 4.3.3 Global Menopause Supplement Revenue Market Share by Type (2021-2032)
5 Menopause Supplement Market by Application
  1. 5.1 Menopause Supplement Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Hospital
  5. 5.2 Global Menopause Supplement Sales by Application
  6. 5.2.1 Global Menopause Supplement Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Menopause Supplement Sales by Application (2021-2032)
  8. 5.2.3 Global Menopause Supplement Sales Market Share by Application (2021-2032)
  9. 5.3 Global Menopause Supplement Revenue by Application
  10. 5.3.1 Global Menopause Supplement Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Menopause Supplement Revenue by Application (2021-2032)
  12. 5.3.3 Global Menopause Supplement Revenue Market Share by Application (2021-2032)
6 Global Menopause Supplement Sales by Region
  1. 6.1 Global Menopause Supplement Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Menopause Supplement Sales by Region (2021-2032)
  3. 6.2.1 Global Menopause Supplement Sales by Region (2021-2026)
  4. 6.2.2 Global Menopause Supplement Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Menopause Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Menopause Supplement Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Menopause Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Menopause Supplement Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Menopause Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Menopause Supplement Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Menopause Supplement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Menopause Supplement Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Menopause Supplement Revenue by Region
  1. 7.1 Global Menopause Supplement Revenue by Region
  2. 7.1.1 Global Menopause Supplement Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Menopause Supplement Revenue by Region (2021-2026)
  4. 7.1.3 Global Menopause Supplement Revenue by Region (2027-2032)
  5. 7.1.4 Global Menopause Supplement Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Menopause Supplement Revenue (2021-2032)
  8. 7.2.2 North America Menopause Supplement Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Menopause Supplement Revenue (2021-2032)
  11. 7.3.2 Europe Menopause Supplement Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Menopause Supplement Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Menopause Supplement Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Menopause Supplement Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Menopause Supplement Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Vitabiotics
  2. 8.1.1 Vitabiotics Company Information
  3. 8.1.2 Vitabiotics Business Overview
  4. 8.1.3 Vitabiotics Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Vitabiotics Menopause Supplement Product Portfolio
  6. 8.1.5 Vitabiotics Recent Developments
  7. 8.2 The Better Menopause
  8. 8.2.1 The Better Menopause Company Information
  9. 8.2.2 The Better Menopause Business Overview
  10. 8.2.3 The Better Menopause Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 The Better Menopause Menopause Supplement Product Portfolio
  12. 8.2.5 The Better Menopause Recent Developments
  13. 8.3 SMPNutra
  14. 8.3.1 SMPNutra Company Information
  15. 8.3.2 SMPNutra Business Overview
  16. 8.3.3 SMPNutra Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SMPNutra Menopause Supplement Product Portfolio
  18. 8.3.5 SMPNutra Recent Developments
  19. 8.4 Promensil
  20. 8.4.1 Promensil Company Information
  21. 8.4.2 Promensil Business Overview
  22. 8.4.3 Promensil Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Promensil Menopause Supplement Product Portfolio
  24. 8.4.5 Promensil Recent Developments
  25. 8.5 PhytoLife Pharma
  26. 8.5.1 PhytoLife Pharma Company Information
  27. 8.5.2 PhytoLife Pharma Business Overview
  28. 8.5.3 PhytoLife Pharma Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PhytoLife Pharma Menopause Supplement Product Portfolio
  30. 8.5.5 PhytoLife Pharma Recent Developments
  31. 8.6 PharmaLinea
  32. 8.6.1 PharmaLinea Company Information
  33. 8.6.2 PharmaLinea Business Overview
  34. 8.6.3 PharmaLinea Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PharmaLinea Menopause Supplement Product Portfolio
  36. 8.6.5 PharmaLinea Recent Developments
  37. 8.7 Otsuka Pharmaceutical
  38. 8.7.1 Otsuka Pharmaceutical Company Information
  39. 8.7.2 Otsuka Pharmaceutical Business Overview
  40. 8.7.3 Otsuka Pharmaceutical Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Otsuka Pharmaceutical Menopause Supplement Product Portfolio
  42. 8.7.5 Otsuka Pharmaceutical Recent Developments
  43. 8.8 Nordic Naturals
  44. 8.8.1 Nordic Naturals Company Information
  45. 8.8.2 Nordic Naturals Business Overview
  46. 8.8.3 Nordic Naturals Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nordic Naturals Menopause Supplement Product Portfolio
  48. 8.8.5 Nordic Naturals Recent Developments
  49. 8.9 New Nordic
  50. 8.9.1 New Nordic Company Information
  51. 8.9.2 New Nordic Business Overview
  52. 8.9.3 New Nordic Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 New Nordic Menopause Supplement Product Portfolio
  54. 8.9.5 New Nordic Recent Developments
  55. 8.10 Menopace
  56. 8.10.1 Menopace Company Information
  57. 8.10.2 Menopace Business Overview
  58. 8.10.3 Menopace Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Menopace Menopause Supplement Product Portfolio
  60. 8.10.5 Menopace Recent Developments
  61. 8.11 MenoLabs
  62. 8.11.1 MenoLabs Company Information
  63. 8.11.2 MenoLabs Business Overview
  64. 8.11.3 MenoLabs Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MenoLabs Menopause Supplement Product Portfolio
  66. 8.11.5 MenoLabs Recent Developments
  67. 8.12 Menoelle
  68. 8.12.1 Menoelle Company Information
  69. 8.12.2 Menoelle Business Overview
  70. 8.12.3 Menoelle Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Menoelle Menopause Supplement Product Portfolio
  72. 8.12.5 Menoelle Recent Developments
  73. 8.13 Makers Nutrition
  74. 8.13.1 Makers Nutrition Company Information
  75. 8.13.2 Makers Nutrition Business Overview
  76. 8.13.3 Makers Nutrition Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Makers Nutrition Menopause Supplement Product Portfolio
  78. 8.13.5 Makers Nutrition Recent Developments
  79. 8.14 Kobayashi Pharmaceutical
  80. 8.14.1 Kobayashi Pharmaceutical Company Information
  81. 8.14.2 Kobayashi Pharmaceutical Business Overview
  82. 8.14.3 Kobayashi Pharmaceutical Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kobayashi Pharmaceutical Menopause Supplement Product Portfolio
  84. 8.14.5 Kobayashi Pharmaceutical Recent Developments
  85. 8.15 GNC
  86. 8.15.1 GNC Company Information
  87. 8.15.2 GNC Business Overview
  88. 8.15.3 GNC Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 GNC Menopause Supplement Product Portfolio
  90. 8.15.5 GNC Recent Developments
  91. 8.16 Flourish
  92. 8.16.1 Flourish Company Information
  93. 8.16.2 Flourish Business Overview
  94. 8.16.3 Flourish Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Flourish Menopause Supplement Product Portfolio
  96. 8.16.5 Flourish Recent Developments
  97. 8.17 Equelle
  98. 8.17.1 Equelle Company Information
  99. 8.17.2 Equelle Business Overview
  100. 8.17.3 Equelle Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Equelle Menopause Supplement Product Portfolio
  102. 8.17.5 Equelle Recent Developments
  103. 8.18 Bonafide Health
  104. 8.18.1 Bonafide Health Company Information
  105. 8.18.2 Bonafide Health Business Overview
  106. 8.18.3 Bonafide Health Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bonafide Health Menopause Supplement Product Portfolio
  108. 8.18.5 Bonafide Health Recent Developments
  109. 8.19 Biofarma Group
  110. 8.19.1 Biofarma Group Company Information
  111. 8.19.2 Biofarma Group Business Overview
  112. 8.19.3 Biofarma Group Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Biofarma Group Menopause Supplement Product Portfolio
  114. 8.19.5 Biofarma Group Recent Developments
  115. 8.20 Amerifit Brands(Estroven)
  116. 8.20.1 Amerifit Brands(Estroven) Company Information
  117. 8.20.2 Amerifit Brands(Estroven) Business Overview
  118. 8.20.3 Amerifit Brands(Estroven) Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Amerifit Brands(Estroven) Menopause Supplement Product Portfolio
  120. 8.20.5 Amerifit Brands(Estroven) Recent Developments
  121. 8.21 AdvaCare Pharma
  122. 8.21.1 AdvaCare Pharma Company Information
  123. 8.21.2 AdvaCare Pharma Business Overview
  124. 8.21.3 AdvaCare Pharma Menopause Supplement Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 AdvaCare Pharma Menopause Supplement Product Portfolio
  126. 8.21.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Menopause Supplement Value Chain Analysis
  2. 9.1.1 Menopause Supplement Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Menopause Supplement Production Mode & Process
  6. 9.2 Menopause Supplement Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Menopause Supplement Distributors
  9. 9.2.3 Menopause Supplement Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst